Mdxhealth Sa stock is traded at $0.1406, with a volume of 1,229,739. It is down -4.03% in the last 24 hours and down -76.72% over the past month. MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Previous Close:
$0.1465
Open:
$0.1462
24h Volume:
1,229,739
Relative Volume:
1.44
Market Cap:
$13.42M
Revenue:
$110.97M
Net Income/Loss:
-$33.18M
P/E Ratio:
-
EPS:
-$0.6574
Net Cash Flow:
-$11.80M
1W Performance:
-6.89%
1M Performance:
-76.72%
6M Performance:
-92.48%
1Y Performance:
-96.59%
1-Day Range:
$0.1371$0.1549
1-Week Range:
$0.1371$0.1734
52-Week Range:
$0.1371$4.49
Mdxhealth Sa Stock (MDXH) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS